Maintenance dosing after achieving goal weight often allows reduction to 1.8-2.0mg weekly for both peptides, providing 20-30% cost savings while sustaining results
Step 2: Identify your vial concentration
In the STEP 1 trial, semaglutide at 2.4 mg weekly produced nearly 15 percent average weight loss over 68 weeks
Flexibility: Month-to-month treatment with no contracts and easy cancellation
HK-Cu Copper Peptide in Laboratory Studies GHK-Cu Copper Peptide for Laboratory Research Applications is a tripeptide complexed with copper that scientists use to investigate tissue regeneration, collagen production, and cellular repair pathways in controlled lab environments
GLP-1 drugs can cause side effects such as nausea, vomiting, diarrhea, and, less commonly, pancreatitis (a serious inflammation of the pancreas)